Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Covington
Healthtrust
Mallinckrodt
Baxter
Citi

Generated: September 20, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: balsalazide disodium

  Try a free trial


See Plans and Pricing

« Back to Dashboard

balsalazide disodium

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Apotex Inc BALSALAZIDE DISODIUM balsalazide disodium CAPSULE;ORAL 077883 ANDA AvKARE, Inc. 42291-157-28 280 CAPSULE in 1 BOTTLE (42291-157-28)
Apotex Inc BALSALAZIDE DISODIUM balsalazide disodium CAPSULE;ORAL 077883 ANDA AvPAK 50268-102-13 30 BLISTER PACK in 1 BOX (50268-102-13) > 1 CAPSULE in 1 BLISTER PACK (50268-102-11)
Apotex Inc BALSALAZIDE DISODIUM balsalazide disodium CAPSULE;ORAL 077883 ANDA Apotex Corp. 60505-2575-0 10 BLISTER PACK in 1 CARTON (60505-2575-0) > 10 CAPSULE in 1 BLISTER PACK
Apotex Inc BALSALAZIDE DISODIUM balsalazide disodium CAPSULE;ORAL 077883 ANDA Apotex Corp. 60505-2575-3 30 CAPSULE in 1 BOTTLE (60505-2575-3)
Apotex Inc BALSALAZIDE DISODIUM balsalazide disodium CAPSULE;ORAL 077883 ANDA Apotex Corp. 60505-2575-4 350 CAPSULE in 1 BOTTLE (60505-2575-4)
Apotex Inc BALSALAZIDE DISODIUM balsalazide disodium CAPSULE;ORAL 077883 ANDA Apotex Corp. 60505-2575-7 280 CAPSULE in 1 BOTTLE (60505-2575-7)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
UBS
Johnson and Johnson
Julphar
Express Scripts
McKinsey